This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to www.ahrq.gov for current information.
Database III: Genetic tests in development
Database of genetic tests in development
Table III-2: Test (by other types
of cancer)
Return to Contents
| Name |
Other Cancer |
Developer |
Data Source |
| AFP-L3 |
|
Wako |
LexisNexis |
| Alpha Catenin |
|
|
EDRN |
| APC |
|
|
EDRN |
| BAT-26 |
|
|
EDRN |
| Bladder cancer test |
Bladder |
ChondroGene, MSKCC |
LexisNexis |
| BladderChek |
Bladder |
M.D. Anderson C.C, Matritech Inc. |
LexisNexis |
| Breast Cancer Detection |
|
IMI International |
CHI |
| Breast Cancer Outcome Prediction Test |
|
Epigenomics, Roche Diagnostics |
LexisNexis |
| Cancer antigen 72-4 |
Stomach |
Roche Diagnostics |
Roche Diagnostics |
| CDK family |
|
M.D. Anderson |
LexisNexis |
| CDKN24 |
|
|
EDRN |
| CDP/Cux |
|
DiagnoCure, McGill U. |
LexisNexis |
| CellSearch |
|
Immunicon, Veridex. Quest Diagnostics |
LexisNexis, CHI |
| CeMines CellCorrect Lab |
|
CeMines |
LexisNexis |
| Chromosome 8q gain |
|
|
ClinicalTrials.gov |
| c-Kit pharmDx |
GIST |
DakoCytomation |
LexisNexis |
| Colorectal cancer test |
|
Microprevention Tests |
LexisNexis |
| Colorectal gene panel |
|
Quest diagnostics |
LexisNexis |
| Colorectalert |
|
IMI Medical |
LexisNexis, CHI |
| Conversion Analysis |
|
GMP Companies, Cleveland Clinic |
LexisNexis |
| Cox-2 RNA |
|
|
EDRN |
| cPSA |
|
|
FDA |
| CupPrint |
Tumor of unknown origin |
Agendia |
LexisNexis |
| Cyfra 21-1 |
|
Roche Diagnostics |
Roche Diagnostics |
| Cytokeratin 20 |
|
Roche Diagnostics |
Roche Diagnostics |
| CytoVision |
|
Applied Imaging Corp |
LexisNexis |
| des-gamma carboxyprothrombin |
|
|
EDRN |
| DNA methylation |
Kidney |
|
Google news, CHI |
| DNA methylation |
|
Orion Genomics, Methexis, Roche, Sequenom |
LexisNexis, CHI |
| EEF1A2 |
|
|
CISTI |
| EGFR |
Cervical, endometrial |
|
EDRN, ClinicalTrials.gov, CHI |
| EGFR |
|
Genzyme, DFCI, MGH |
LexisNexis |
| EPCA |
|
Tessera, Johns Hopkins U |
LexisNexis |
| eTag |
|
ViroLogic, AstraZeneca |
LexisNexis, CHI |
| Genomic Test |
|
|
ClinicalTrials.gov |
| GOS |
|
|
EDRN |
| GSTM1 |
|
|
Google news |
| GSTP1 |
|
|
EDRN, Google news |
| Her-1, Her-2, Her-3, Her-4 |
|
Roche Diagnostics |
Roche Diagnostics |
| HLA-E |
Gliomas |
|
Google news |
| HP1alpha |
|
|
CISTI |
| HPV test |
Cervical |
Diagene, GenoID |
LexisNexis |
| HPV test |
Cervical |
Roche Diagnostics |
Roche Diagnostics |
| IGF-II |
Cervical, endometrial |
|
EDRN |
| IMI breast cancer test |
|
IMI Medical |
LexisNexis |
| Immunocyt/ uCyt |
Bladder |
DiagnoCure, Gen-Probe |
LexisNexis |
| Iressa test |
|
U of Tokyo, AstraZeneca |
LexisNexis |
| Key2 |
|
Exagen |
LexisNexis |
| K-ras |
|
|
EDRN |
| Leukemia Affymetrix Chip |
|
Roche Diagnostics |
Roche Diagnostics |
| Leukemia blood test |
|
Genzyme |
CHI |
| Lung cancer test |
|
Cangen Biotech, Olympus |
LexisNexis |
| Lung cancer test |
|
Cleveland Clinic |
LexisNexis |
| LungAlert |
|
IMI Medical |
LexisNexis |
| Lysophopholipids |
|
|
ClinicalTrials.gov |
| M2-PK |
|
Giessen U |
LexisNexis |
| MammaPrint |
|
Agendia, Transbig, Molecular Profiling Institute |
LexisNexis |
| Matrix metalloproeinases |
|
|
ClinicalTrials.gov |
| Melanoma inhibiting antigen |
Melanoma |
Roche Diagnostics |
Roche Diagnostics |
| Melastatin |
Melanoma |
|
ClinicalTrials.gov |
| MESOMARK |
Mesothelioma |
Fujirebio Diagnostics |
LexisNexis |
| MGMT |
|
|
EDRN |
| Microsatelitte Analysis |
Bladder |
|
ClinicalTrials.gov |
| MLH1 |
|
|
EDRN |
| MN protein |
|
|
ClinicalTrials.gov |
| MSA |
Bladder |
|
EDRN, ClinicalTrials.gov |
| MSA analysis |
Bladder |
Cangen Biotech |
LexisNexis |
| NAF test |
|
Power3 |
LexisNexis |
| NMP179 |
Cervical |
Matritech Inc. |
LexisNexis |
| NMP22 |
Bladder |
|
FDA/ CHI |
| NMP35 |
|
Matritech Inc. |
LexisNexis |
| NMP48 |
|
Matritech Inc. |
LexisNexis |
| NMP66 |
|
Matritech Inc. |
LexisNexis, CHI |
| OncoVue breast cancer risk test |
|
Tm Bioscience/ Intergenetics |
LexisNexis, CHI |
| Ovacheck |
|
Quest, LabCorp, Correlogic |
LexisNexis |
| Ovarian cancer biomarker test |
|
Ciphergen Biosystems, Johns Hopkins |
LexisNexis |
| Ovarian cancer test |
|
Yale U |
LexisNexis |
| Ovarian cancer test |
|
Beth Israel Deaconess Medical Center |
LexisNexis |
| Ovarian pap test |
|
|
ClinicalTrials.gov |
| p16, p15, p14 deletions |
All |
|
ClinicalTrials.gov |
| p202 |
|
|
CISTI |
| p53 Affymetrix Chip |
Others |
Roche Diagnostics |
Roche Diagnostics |
| Prostate 63 |
|
|
CLIA |
| Prostate biomarkers |
|
Health Discovery Corporation/Stanford U |
CHI |
| Prostate Cancer Blood Test |
|
Correlogic |
CHI |
| Protein Profile test |
|
|
ClinicalTrials.gov |
| PSA testing |
|
Qualigen, Healthtronics |
LexisNexis |
| PSMA |
|
Cytogen |
CHI |
| PSP94 |
|
Procyon, Medicorp |
LexisNexis |
| PTEN tumor suppressor |
|
|
CISTI |
| PyloriProbe |
|
AMDL |
LexisNexis |
| Recaf |
|
Abbot, BioCurex |
LexisNexis |
| RhoC GTPase |
|
|
CISTI |
| S100 |
Melanoma |
Roche Diagnostics |
Roche Diagnostics |
| SELDI-TOF-MS |
|
|
EDRN |
| SurePath |
Cervical |
Tripath Imaging |
LexisNexis |
| Telomerase |
Bladder |
Roche Diagnostics |
Roche Diagnostics |
| TGF genes |
|
|
Google news |
| TUO test |
Tumor of unknown origin |
US LABS |
LexisNexis |
| uPM3 |
|
DiagnoCure, Gen-Probe |
LexisNexis |
| Urinary plasminogen activator |
|
|
ClinicalTrials.gov |
| Urine test for cervical cancer |
Cervical |
U. Washington |
LexisNexis |
| VEGF |
|
Quest |
LexisNexis |
| WISP3 |
|
|
CISTI |
Return to Contents
Proceed to Next Section
|
540 Gaither Road Rockville, MD 20850